Cellular and molecular action of the mitogenic protein-deamidating toxin from Pasteurella multocida

FEBS Journal

Volumn 278, Issue 23, 2011, Pages 4616-4632

  Wilson, Brenda A ^a   Ho, Mengfei ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

adipogenesis; atrophic rhinitis; deamidation; dermonecrotic toxin; G protein; membrane translocation; mitogenesis; osteogenesis; receptor mediated endocytosis; transglutamination

Indexed keywords

ACYLTRANSFERASE; BACTERIAL TOXIN; CALCIUM; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PASTEURELLA MULTOCIDA TOXIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL DISEASE; ATROPHIC RHINITIS; BONE DEVELOPMENT; CALCIUM SIGNALING; CELL ACTIVITY; CYTOSKELETAL SIGNALLING; CYTOTOXICITY; DEAMINATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; EPIZOOTIC DISEASE; GROWTH RETARDATION; HUMAN; IMMUNOREACTIVITY; KIDNEY DISEASE; LIVER NECROSIS; MITOGENIC SIGNALLING; NONHUMAN; NUCLEOTIDE SEQUENCE; PASTEURELLA MULTOCIDA; PASTEURELLA MULTOCIDA INFECTION; PNEUMONIA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPLEEN DISEASE; TOXIN STRUCTURE; WEIGHT REDUCTION; ZOONOSIS;

ADIPOGENESIS; BACTERIAL TOXINS; CELL PROLIFERATION; CYCLIC AMP; CYTOTOXINS; GTP-BINDING PROTEINS; MITOSIS; OSTEOGENESIS; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

BORDETELLA; ESCHERICHIA COLI; PASTEURELLA MULTOCIDA; YERSINIA;

EID: 81555195261     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08158.x     Document Type: Review

References (156)

1. Wilson BA, (2008) Global biosecurity in a complex, dynamic world. Complexity 14, 71-88.
2. Wilson BA, &, Salyers AA, (2002) Ecology and physiology of infectious bacteria-implications for biotechnology. Curr Opin Biotechnol 13, 267-274. (Pubitemid 35299548)
3. Wilson BA, &, Ho M, (2010) Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins. Future Microbiol 5, 1185-1201.
4. Fiorentini C, Fabbri A, Flatau G, Donelli G, Matarrese P, Lemichez E, Falzano L, &, Boquet P, (1997) Escherichia coli cytotoxic necrotizing factor 1 (CNF1), a toxin that activates the Rho GTPase. J Biol Chem 272, 19532-19537. (Pubitemid 27337754)
5. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, &, Boquet P, (1997) Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387, 729-733. (Pubitemid 27270616)
6. Horiguchi Y, (2001) Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin: the dermonecrosis-inducing toxins activating Rho small GTPases. Toxicon 39, 1619-1627. (Pubitemid 32786995)
7. Oswald E, Sugai M, Labigne A, Wu HC, Fiorentini C, Boquet P, &, O'Brien AD, (1994) Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc Natl Acad Sci USA 91, 3814-3818. (Pubitemid 24139522)
8. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, &, Aktories K, (1997) Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387, 725-729. (Pubitemid 27270615)
9. Horiguchi Y, Inoue N, Masuda M, Kashimoto T, Katahira J, Sugimoto N, &, Matsuda M, (1997) Bordetella bronchiseptica dermonecrotizing toxin induces reorganization of actin stress fibers through deamidation of Gln-63 of the GTP-binding protein Rho. Proc Natl Acad Sci USA 94, 11623-11626.
10. Horiguchi Y, Senda T, Sugimoto N, Katahira J, &, Matsuda M, (1995) Bordetella bronchiseptica dermonecrotizing toxin stimulates assembly of actin stress fibers and focal adhesions by modifying the small GTP-binding protein rho. J Cell Sci 108, 3243-3251.
11. Ohnishi T, Horiguchi Y, Masuda M, Sugimoto N, &, Matsuda M, (1998) Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. J Vet Med Sci 60, 301-305. (Pubitemid 128529401)
12. Masuda M, Minami M, Shime H, Matsuzawa T, &, Horiguchi Y, (2002) In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin. Infect Immun 70, 998-1001. (Pubitemid 34083867)
13. Flatau G, Landraud L, Boquet P, Bruzzone M, &, Munro P, (2000) Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain. Biochem Biophys Res Commun 267, 588-592. (Pubitemid 30076842)
14. Sugai M, Hatazaki K, Mogami A, Ohta H, Peres SY, Herault F, Horiguchi Y, Masuda M, Ueno Y, Komatsuzawa H, et al. (1999) Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a Gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1. Infect Immun 67, 6550-6557.
15. Hoffmann C, &, Schmidt G, (2004) CNF and DNT. Rev Physiol Biochem Pharmacol 152, 49-63. (Pubitemid 44404357)
16. Hoffmann C, Pop M, Leemhuis J, Schirmer J, Aktories K, &, Schmidt G, (2004) The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. J Biol Chem 279, 16026-16032. (Pubitemid 38509292)
17. Schmidt G, Goehring UM, Schirmer J, Uttenweiler-Joseph S, Wilm M, Lohmann M, Giese A, Schmalzing G, &, Aktories K, (2001) Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxin. Infect Immun 69, 7663-7670. (Pubitemid 33086595)
18. Orth JH, Preuss I, Fester I, Schlosser A, Wilson BA, &, Aktories K, (2009) Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc Natl Acad Sci USA 106, 7179-7184.
19. Ackermann MR, DeBey MC, Register KB, Larson DJ, &, Kinyon JM, (1994) Tonsil and turbinate colonization by toxigenic and nontoxigenic strains of Pasteurella multocida in conventionally raised swine. J Vet Diagn Invest 6, 375-377.
20. Deeb BJ, DiGiacomo RF, Bernard BL, &, Silbernagel SM, (1990) Pasteurella multocida and Bordetella bronchiseptica infections in rabbits. J Clin Microbiol 28, 70-75. (Pubitemid 20016780)
21. DiGiacomo RF, Deeb BJ, Brodie SJ, Zimmerman TE, Veltkamp ER, &, Chrisp CE, (1993) Toxin production by Pasteurella multocida isolated from rabbits with atrophic rhinitis. Am J Vet Res 54, 1280-1286.
22. Magyar T, (1989) Study of the toxin-producing ability of Pasteurella multocida in mice. Acta Vet Hung 37, 319-325.
23. Foged NT, (1992) Pasteurella multocida toxin. The characterisation of the toxin and its significance in the diagnosis and prevention of progressive atrophic rhinitis in pigs. APMIS Suppl 25, 1-56.
24. Frymus T, Bielecki W, &, Jakubowski T, (1991) Toxigenic Pasteurella multocida in rabbits with naturally occurring atrophic rhinitis. Zentralbl Veterinarmed B 38, 265-268.
25. Lax AJ, &, Chanter N, (1990) Cloning of the toxin gene from Pasteurella multocida and its role in atrophic rhinitis. J Gen Microbiol 136, 81-87. (Pubitemid 20045973)
26. Williams PP, Hall MR, &, Rimler RB, (1990) Host response to Pasteurella multocida turbinate atrophy toxin in swine. Can J Vet Res 54, 157-163.
27. Digiacomo RF, Allen V, &, Hinton MH, (1991) Naturally acquired Pasteurella multocida subsp. multocida infection in a closed colony of rabbits: characteristics of isolates. Lab Anim 25, 236-241.
28. DiGiacomo RF, Xu YM, Allen V, Hinton MH, &, Pearson GR, (1991) Naturally acquired Pasteurella multocida infection in rabbits: clinicopathological aspects. Can J Vet Res 55, 234-238.
29. Kielstein P, (1986) On the occurrence of toxin-producing Pasteurella multocida strains in atrophic rhinitis and in pneumonias of swine and cattle. Zentralbl Veterinarmed B 33, 418-424.
30. Cheville NF, &, Rimler RB, (1989) A protein toxin from Pasteurella multocida type D causes acute and chronic hepatic toxicity in rats. Vet Pathol 26, 148-157.
31. Chrisp CE, &, Foged NT, (1991) Induction of pneumonia in rabbits by use of a purified protein toxin from Pasteurella multocida. Am J Vet Res 52, 56-61.
32. Glavits R, &, Magyar T, (1990) The pathology of experimental respiratory infection with Pasteurella multocida and Bordetella bronchiseptica in rabbits. Acta Vet Hung 38, 211-215.
33. Hoskins IC, Thomas LH, &, Lax AJ, (1997) Nasal infection with Pasteurella multocida causes proliferation of bladder epithelium in gnotobiotic pigs. Vet Rec 140, 22. (Pubitemid 127777151)
34. Klein NC, &, Cunha BA, (1997) Pasteurella multocida pneumonia. Semin Respir Infect 12, 54-56. (Pubitemid 27163592)
35. Magyar T, &, Glavits R, (1990) Immunopathological changes in mice caused by Bordetella bronchiseptica and Pasteurella multocida. Acta Vet Hung 38, 203-210.
36. Ackermann MR, Register KB, Stabel JR, Gwaltney SM, Howe TS, &, Rimler RB, (1996) Effect of Pasteurella multocida toxin on physeal growth in young pigs. Am J Vet Res 57, 848-852. (Pubitemid 126501059)
37. Arashima Y, &, Kumasaka K, (2005) Pasteurellosis as zoonosis. Intern Med 44, 692-693. (Pubitemid 41093818)
38. Garcia VF, (1997) Animal bites and Pasturella infections. Pediatr Rev 18, 127-130.
39. Griego RD, Rosen T, Orengo IF, &, Wolf JE, (1995) Dog, cat, and human bites: a review. J Am Acad Dermatol 33, 1019-1029.
40. Kobayaa H, Souki RR, Trust S, &, Domachowske JB, (2009) Pasteurella multocida meningitis in newborns after incidental animal exposure. Pediatr Infect Dis J 28, 928-929.
41. Migliore E, Serraino C, Brignone C, Ferrigno D, Cardellicchio A, Pomero F, Castagna E, Osenda M, &, Fenoglio L, (2009) Pasteurella multocida infection in a cirrhotic patient: case report, microbiological aspects and a review of literature. Adv Med Sci 54, 109-112.
42. Waldor M, Roberts D, &, Kazanjian P, (1992) In utero infection due to Pasteurella multocida in the first trimester of pregnancy: case report and review. Clin Infect Dis 14, 497-500.
43. Frederiksen W, (1993) Ecology and significance of Pasteurellaceae in man-an update. Zentralbl Bakteriol 279, 27-34.
44. Donnio PY, Allardet-Servent A, Perrin M, Escande F, &, Avril JL, (1999) Characterisation of dermonecrotic toxin-producing strains of Pasteurella multocida subsp. multocida isolated from man and swine. J Med Microbiol 48, 125-131. (Pubitemid 29371595)
45. Donnio PY, Lerestif-Gautier AL, &, Avril JL, (2004) Characterization of Pasteurella spp. strains isolated from human infections. J Comp Pathol 130, 137-142. (Pubitemid 38279330)
46. Holst E, Rollof J, Larsson L, &, Nielsen JP, (1992) Characterization and distribution of Pasteurella species recovered from infected humans. J Clin Microbiol 30, 2984-2987.
47. Henderson SR, Shah A, Banford KB, &, Howard LS, (2010) Pig trotters lung-novel domestic transmission of Pasteurella multocida. Clin Med 10, 517-518.
48. Iaria C, &, Cascio A, (2007) Please, do not forget Pasteurella multocida. Clin Infect Dis 45, 940. (Pubitemid 47580393)
49. Satomura A, Yanai M, Fujita T, Arashima Y, Kumasaka K, Nakane C, Ito K, Fuke Y, Maruyama T, Maruyama N, et al. (2010) Peritonitis associated with Pasteurella multocida: molecular evidence of zoonotic etiology. Ther Apher Dial 14, 373-376.
50. Wilson BA, &, Ho M, (2006) Pasteurella multocida toxin. In The Comprehensive Sourcebook of Bacterial Protein Toxins (, Alouf JE, &, Popoff MR, eds), pp. 430-447. Elsevier Science Publishers BV, Amsterdam.
51. Cheville NF, Rimler RB, &, Thurston JR, (1988) A toxin from Pasteurella multocida type D causes acute hepatic necrosis in pigs. Vet Pathol 25, 518-520.
52. Nakai T, Sawata A, Tsuji M, &, Kume K, (1984) Characterization of dermonecrotic toxin produced by serotype D strains of Pasteurella multocida. Am J Vet Res 45, 2410-2413. (Pubitemid 15217459)
53. Thurston JR, Rimler RB, Ackermann MR, &, Cheville NF, (1992) Use of rats to compare atrophic rhinitis vaccines for protection against effects of heat-labile protein toxin produced by Pasteurella multocida serogroup D. Vet Immunol Immunopathol 33, 155-162.
54. Ackermann MR, Stabel JR, Pettit RK, Jacobson CD, Elmquist JK, Register KB, Rimler RB, &, Hilton JH, (1995) Reduced physeal area and chondrocyte proliferation in Pasteurella multocida toxin-treated rats. Vet Pathol 32, 674-682.
55. Al-Haddawi MH, Jasni S, Israf DA, Zamri-Saad M, Mutalib AR, &, Sheikh-Omar AR, (2001) Ultrastructural pathology of nasal and tracheal mucosa of rabbits experimentally infected with Pasteurella multocida serotype D:1. Res Vet Sci 70, 191-197. (Pubitemid 33636594)
56. Kimman TG, Lowik CW, van de Wee-Pals LJ, Thesingh CW, Defize P, Kamp EM, &, Bijvoet OL, (1987) Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida. Infect Immun 55, 2110-2116.
57. Mullan PB, &, Lax AJ, (1996) Pasteurella multocida toxin is a mitogen for bone cells in primary culture. Infect Immun 64, 959-965. (Pubitemid 26065573)
58. Mullan PB, &, Lax AJ, (1998) Pasteurella multocida toxin stimulates bone resorption by osteoclasts via interaction with osteoblasts. Calcif Tissue Int 63, 340-345. (Pubitemid 28443419)
59. Jutras I, &, Martineau-Doize B, (1996) Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures. Can J Vet Res 60, 34-39. (Pubitemid 126504262)
60. Martineau-Doize B, Caya I, Gagne S, Jutras I, &, Dumas G, (1993) Effects of Pasteurella multocida toxin on the osteoclast population of the rat. J Comp Pathol 108, 81-91. (Pubitemid 23098649)
61. Felix R, Fleisch H, &, Frandsen PL, (1992) Effect of Pasteurella multocida toxin on bone resorption in vitro. Infect Immun 60, 4984-4988.
62. Gwaltney SM, Galvin RJ, Register KB, Rimler RB, &, Ackermann MR, (1997) Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts. Vet Pathol 34, 421-430. (Pubitemid 127470275)
63. Harmey D, Stenbeck G, Nobes CD, Lax AJ, &, Grigoriadis AE, (2004) Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res 19, 661-670. (Pubitemid 41071227)
64. Sterner-Kock A, Lanske B, Uberschar S, &, Atkinson MJ, (1995) Effects of the Pasteurella multocida toxin on osteoblastic cells in vitro. Vet Pathol 32, 274-279.
65. Rozengurt E, Higgins T, Chanter N, Lax AJ, &, Staddon JM, (1990) Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc Natl Acad Sci USA 87, 123-127.
66. Seo B, Choy EW, Maudsley S, Miller WE, Wilson BA, &, Luttrell LM, (2000) Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-dependent transactivation of the epidermal growth factor receptor. J Biol Chem 275, 2239-2245. (Pubitemid 30060855)
67. Wilson BA, Aminova LR, Ponferrada VG, &, Ho M, (2000) Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin. Infect Immun 68, 4531-4538. (Pubitemid 30497720)
68. Aminova LR, &, Wilson BA, (2007) Calcineurin-independent inhibition of 3T3-L1 adipogenesis by Pasteurella multocida toxin: suppression of Notch1, stabilization of beta-catenin and pre-adipocyte factor 1. Cell Microbiol 9, 2485-2496. (Pubitemid 47365652)
69. Preuss I, Hildebrand D, Orth JH, Aktories K, &, Kubatzky KF, (2010) Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways. Cell Microbiol 12, 1174-1185.
70. Sabri A, Wilson BA, &, Steinberg SF, (2002) Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ Res 90, 850-857. (Pubitemid 34633876)
71. 2+ in Swiss 3T3 cells. J Biol Chem 266, 4840-4847. (Pubitemid 21909431)
72. Wilson BA, Zhu X, Ho M, &, Lu L, (1997) Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem 272, 1268-1275. (Pubitemid 27034627)
73. Aepfelbacher M, &, Essler M, (2001) Disturbance of endothelial barrier function by bacterial toxins and atherogenic mediators: a role for Rho/Rho kinase. Cell Microbiol 3, 649-658. (Pubitemid 32976336)
74. Orth JH, Lang S, Taniguchi M, &, Aktories K, (2005) Pasteurella multocida toxin-induced activation of RhoA is mediated via two families of G{alpha} proteins, G{alpha}q and G{alpha}12/13. J Biol Chem 280, 36701-36707. (Pubitemid 41587748)
75. Sagi SA, Seasholtz TM, Kobiashvili M, Wilson BA, Toksoz D, &, Brown JH, (2001) Physical and functional interactions of Galphaq with Rho and its exchange factors. J Biol Chem 276, 15445-15452.
76. Orth JH, Fester I, Preuss I, Agnoletto L, Wilson BA, &, Aktories K, (2008) Activation of Galpha(i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin. J Biol Chem 283, 23288-23294.
77. Staddon JM, Chanter N, Lax AJ, Higgins TE, &, Rozengurt E, (1990) Pasteurella multocida toxin, a potent mitogen, stimulates protein kinase C-dependent and -independent protein phosphorylation in Swiss 3T3 cells. J Biol Chem 265, 11841-11848.
78. Luo S, Ho M, &, Wilson BA, (2008) Application of intact cell-based NFAT-beta-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway. Toxicon 51, 597-605.
79. Staddon JM, Bouzyk MM, &, Rozengurt E, (1992) Interconversion of GRP78/BiP. A novel event in the action of Pasteurella multocida toxin, bombesin, and platelet-derived growth factor. J Biol Chem 267, 25239-25245.
80. Lacerda HM, Lax AJ, &, Rozengurt E, (1996) Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J Biol Chem 271, 439-445.
81. Obreztchikova M, Elouardighi H, Ho M, Wilson BA, Gertsberg Z, &, Steinberg SF, (2006) Distinct signaling functions for Shc isoforms in the heart. J Biol Chem 281, 20197-20204. (Pubitemid 44065794)
82. Ozgen N, Obreztchikova M, Guo J, Elouardighi H, Dorn GW II, Wilson BA, &, Steinberg SF, (2008) Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart. J Biol Chem 283, 17009-17019.
83. Aminova LR, Luo S, Bannai Y, Ho M, &, Wilson BA, (2008) The C3 domain of Pasteurella multocida toxin is the minimal domain responsible for activation of Gq-dependent calcium and mitogenic signaling. Protein Sci 17, 945-949. (Pubitemid 351629589)
84. Zywietz A, Gohla A, Schmelz M, Schultz G, &, Offermanns S, (2001) Pleiotropic effects of Pasteurella multocida toxin are mediated by Gq-dependent and -independent mechanisms. involvement of Gq but not G11. J Biol Chem 276, 3840-3845.
85. Hildebrand D, Heeg K, &, Kubatzky KF, (2010) Pasteurella multocida toxin-stimulated osteoclast differentiation is B cell dependent. Infect Immun 79, 220-228.
86. Hildebrand D, Walker P, Dalpke A, Heeg K, &, Kubatzky KF, (2010) Pasteurella multocida toxin-induced Pim-1 expression disrupts suppressor of cytokine signalling (SOCS)-1 activity. Cell Microbiol 12, 1732-1745.
87. Orth JH, Aktories K, &, Kubatzky KF, (2007) Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin. J Biol Chem 282, 3050-3057. (Pubitemid 47084349)
88. Sternweis PC, &, Smrcka AV, (1992) Regulation of phospholipase C by G proteins. Trends Biochem Sci 17, 502-506.
89. Orth JH, Lang S, &, Aktories K, (2004) Action of Pasteurella multocida toxin depends on the helical domain of Galphaq. J Biol Chem 279, 34150-34155. (Pubitemid 39318037)
90. Orth JH, Lang S, Preuss I, Milligan G, &, Aktories K, (2007) Action of Pasteurella multocida toxin on Galpha(q) is persistent and independent of interaction with G-protein-coupled receptors. Cell Signal 19, 2174-2182. (Pubitemid 47353820)
91. Murphy AC, &, Rozengurt E, (1992) Pasteurella multocida toxin selectively facilitates phosphatidylinositol 4,5-bisphosphate hydrolysis by bombesin, vasopressin, and endothelin. Requirement for a functional G protein. J Biol Chem 267, 25296-25303.
92. Hennig B, Orth J, Aktories K, &, Diener M, (2008) Anion secretion evoked by Pasteurella multocida toxin across rat colon. Eur J Pharmacol 583, 156-163.
93. Lax AJ, (2005) Opinion: bacterial toxins and cancer-a case to answer? Nat Rev Microbiol 3, 343-349. (Pubitemid 40443727)
94. Rutter JM, &, Luther PD, (1984) Cell culture assay for toxigenic Pasteurella multocida from atrophic rhinitis of pigs. Vet Rec 114, 393-396.
95. Pennings AM, &, Storm PK, (1984) A test in vero cell monolayers for toxin production by strains of Pasteurella multocida isolated from pigs suspected of having atrophic rhinitis. Vet Microbiol 9, 503-508. (Pubitemid 14039120)
96. Pettit RK, Ackermann MR, &, Rimler RB, (1993) Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells. Lab Invest 69, 94-100. (Pubitemid 23222251)
97. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, &, Dorn GW II, (1998) Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95, 10140-10145. (Pubitemid 28415308)
98. Wang QJ, (2006) PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 27, 317-323. (Pubitemid 43850003)
99. Dudet LI, Chailler P, Dubreuil JD, &, Martineau-Doize B, (1996) Pasteurella multocida toxin stimulates mitogenesis and cytoskeleton reorganization in Swiss 3T3 fibroblasts. J Cell Physiol 168, 173-182. (Pubitemid 26233446)
100. Thomas W, Pullinger GD, Lax AJ, &, Rozengurt E, (2001) Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association. Infect Immun 69, 5931-5935. (Pubitemid 32786538)
101. Essler M, Hermann K, Amano M, Kaibuchi K, Heesemann J, Weber PC, &, Aepfelbacher M, (1998) Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase. J Immunol 161, 5640-5646. (Pubitemid 28519131)
102. Lacerda HM, Pullinger GD, Lax AJ, &, Rozengurt E, (1997) Cytotoxic necrotizing factor 1 from Escherichia coli and dermonecrotic toxin from Bordetella bronchiseptica induce p21(rho)-dependent tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 cells. J Biol Chem 272, 9587-9596. (Pubitemid 27154980)
103. Buhl AM, Johnson NL, Dhanasekaran N, &, Johnson GL, (1995) G alpha 12 and G alpha 13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem 270, 24631-24634.
104. Goulimari P, Knieling H, Engel U, &, Grosse R, (2008) LARG and mDia1 link Galpha12/13 to cell polarity and microtubule dynamics. Mol Biol Cell 19, 30-40. (Pubitemid 351186130)
105. Jin S, &, Exton JH, (2000) Activation of RhoA by association of Galpha(13) with Dbl. Biochem Biophys Res Commun 277, 718-721.
106. Tanabe S, Kreutz B, Suzuki N, &, Kozasa T, (2004) Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins. Methods Enzymol 390, 285-294. (Pubitemid 39370658)
107. Lutz S, Freichel-Blomquist A, Yang Y, Rumenapp U, Jakobs KH, Schmidt M, &, Wieland T, (2005) The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J Biol Chem 280, 11134-11139. (Pubitemid 40418419)
108. Elling F, Pedersen KB, Hogh P, &, Foged NT, (1988) Characterization of the dermal lesions induced by a purified protein from toxigenic Pasteurella multocida. APMIS 96, 50-55. (Pubitemid 18085779)
109. Katada T, Oinuma M, &, Ui M, (1986) Two guanine nucleotide-binding proteins in rat brain serving as the specific substrate of islet-activating protein, pertussis toxin. Interaction of the alpha-subunits with beta gamma-subunits in development of their biological activities. J Biol Chem 261, 8182-8191. (Pubitemid 17213970)
110. Rosen ED, &, Spiegelman BM, (2000) Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16, 145-171. (Pubitemid 32037503)
111. Nuttall ME, &, Gimble JM, (2004) Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4, 290-294. (Pubitemid 38585315)
112. Sul HS, Smas C, Mei B, &, Zhou L, (2000) Function of pref-1 as an inhibitor of adipocyte differentiation. Int J Obes Relat Metab Disord 24 (Suppl 4), S15-S19.
113. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, &, MacDougald OA, (2000) Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953. (Pubitemid 30659947)
114. Liu L, &, Clipstone NA, (2007) Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. J Cell Biochem 100, 161-173. (Pubitemid 44958187)
115. Neal JW, &, Clipstone NA, (2002) Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J Biol Chem 277, 49776-49781. (Pubitemid 36014424)
116. DiGiacomo RF, Deeb BJ, Giddens WE Jr, Bernard BL, &, Chengappa MM, (1989) Atrophic rhinitis in New Zealand white rabbits infected with Pasteurella multocida. Am J Vet Res 50, 1460-1465.
117. Elling F, &, Pedersen KB, (1985) The pathogenesis of persistent turbinate atrophy induced by toxigenic Pasteurella multocida in pigs. Vet Pathol 22, 469-474.
118. Sciaudone M, Gazzerro E, Priest L, Delany AM, &, Canalis E, (2003) Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144, 5631-5639. (Pubitemid 37476092)
119. Bording A, &, Foged NT, (1991) Characterization of the immunogenicity of formaldehyde detoxified Pasteurella multocida toxin. Vet Microbiol 29, 267-280.
120. Chanter N, &, Rutter JM, (1990) Colonisation by Pasteurella multocida in atrophic rhinitis of pigs and immunity to the osteolytic toxin. Vet Microbiol 25, 253-265. (Pubitemid 20369307)
121. Foged NT, Nielsen JP, &, Jorsal SE, (1989) Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies. Vet Rec 125, 7-11.
122. Frymus T, Muller E, Franz B, &, Petzoldt K, (1989) Protection by toxoid-induced antibody of gnotobiotic piglets challenged with the dermonecrotic toxin of Pasteurella multocida. Zentralbl Veterinarmed B 36, 674-680.
123. Pettit RK, Rimler RB, &, Ackermann MR, (1993) Protection of Pasteurella multocida dermonecrotic toxin-challenged rats by toxoid-induced antibody. Vet Microbiol 34, 167-173.
124. Suckow MA, (2000) Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine. Lab Anim 34, 403-408.
125. Bagley KC, Abdelwahab SF, Tuskan RG, &, Lewis GK, (2005) Pasteurella multocida toxin activates human monocyte-derived and murine bone marrow-derived dendritic cells in vitro but suppresses antibody production in vivo. Infect Immun 73, 413-421. (Pubitemid 40041134)
126. Hamilton TD, Roe JM, Hayes CM, &, Webster AJ, (1998) Effect of ovalbumin aerosol exposure on colonization of the porcine upper airway by Pasteurella multocida and effect of colonization on subsequent immune function. Clin Diagn Lab Immunol 5, 494-498. (Pubitemid 28342876)
127. Jordan RW, Hamilton TD, Hayes CM, Patel D, Jones PH, Roe JM, &, Williams NA, (2003) Modulation of the humoral immune response of swine and mice mediated by toxigenic Pasteurella multocida. FEMS Immunol Med Microbiol 39, 51-59. (Pubitemid 37211460)
128. van Diemen PM, de Vries Reilingh G, &, Parmentier HK, (1996) Effect of Pasteurella multocida toxin on in vivo immune responses in piglets. Vet Q 18, 141-146. (Pubitemid 28119966)
129. Thurston JR, Rimler RB, Ackermann MR, Cheville NF, &, Sacks JM, (1991) Immunity induced in rats vaccinated with toxoid prepared from heat-labile toxin produced by Pasteurella multocida serogroup D. Vet Microbiol 27, 169-174.
130. Blocker D, Berod L, Fluhr JW, Orth J, Idzko M, Aktories K, &, Norgauer J, (2006) Pasteurella multocida toxin (PMT) activates RhoGTPases, induces actin polymerization and inhibits migration of human dendritic cells, but does not influence macropinocytosis. Int Immunol 18, 459-464. (Pubitemid 43329608)
131. Kashimoto T, Katahira J, Cornejo WR, Masuda M, Fukuoh A, Matsuzawa T, Ohnishi T, &, Horiguchi Y, (1999) Identification of functional domains of Bordetella dermonecrotizing toxin. Infect Immun 67, 3727-3732. (Pubitemid 29356984)
132. Lemichez E, Flatau G, Bruzzone M, Boquet P, &, Gauthier M, (1997) Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Mol Microbiol 24, 1061-1070. (Pubitemid 27286157)
133. Pullinger GD, Sowdhamini R, &, Lax AJ, (2001) Localization of functional domains of the mitogenic toxin of Pasteurella multocida. Infect Immun 69, 7839-7850. (Pubitemid 33086615)
134. Fabbri A, Gauthier M, &, Boquet P, (1999) The 5′ region of cnf1 harbours a translational regulatory mechanism for CNF1 synthesis and encodes the cell-binding domain of the toxin. Mol Microbiol 33, 108-118. (Pubitemid 29311256)
135. Meysick KC, Mills M, &, O'Brien AD, (2001) Epitope mapping of monoclonal antibodies capable of neutralizing cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli. Infect Immun 69, 2066-2074. (Pubitemid 32239670)
136. Pei S, Doye A, &, Boquet P, (2001) Mutation of specific acidic residues of the CNF1 T domain into lysine alters cell membrane translocation of the toxin. Mol Microbiol 41, 1237-1247. (Pubitemid 32939498)
137. Matsuzawa T, Kashimoto T, Katahira J, &, Horiguchi Y, (2002) Identification of a receptor-binding domain of Bordetella dermonecrotic toxin. Infect Immun 70, 3427-3432. (Pubitemid 34665979)
138. Buetow L, Flatau G, Chiu K, Boquet P, &, Ghosh P, (2001) Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat Struct Biol 8, 584-588. (Pubitemid 32613004)
139. Kitadokoro K, Kamitani S, Miyazawa M, Hanajima-Ozawa M, Fukui A, Miyake M, &, Horiguchi Y, (2007) Crystal structures reveal a thiol protease-like catalytic triad in the C-terminal region of Pasteurella multocida toxin. Proc Natl Acad Sci USA 104, 5139-5144. (Pubitemid 47186189)
140. Schmidt G, Selzer J, Lerm M, &, Aktories K, (1998) The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem 273, 13669-13674. (Pubitemid 28268413)
141. Geissler B, Tungekar R, &, Satchell KJ, (2010) Identification of a conserved membrane localization domain within numerous large bacterial protein toxins. Proc Natl Acad Sci USA 107, 5581-5586.
142. Kamitani S, Kitadokoro K, Miyazawa M, Toshima H, Fukui A, Abe H, Miyake M, &, Horiguchi Y, (2010) Characterization of the membrane-targeting C1 domain in Pasteurella multocida toxin. J Biol Chem 285, 25467-25475.
143. Yee VC, Pedersen LC, Le Trong I, Bishop PD, Stenkamp RE, &, Teller DC, (1994) Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci USA 91, 7296-7300. (Pubitemid 24226850)
144. Noguchi K, Ishikawa K, Yokoyama K, Ohtsuka T, Nio N, &, Suzuki E, (2001) Crystal structure of red sea bream transglutaminase. J Biol Chem 276, 12055-12059.
145. Sinclair JC, Sandy J, Delgoda R, Sim E, &, Noble ME, (2000) Structure of arylamine N-acetyltransferase reveals a catalytic triad. Nat Struct Biol 7, 560-564. (Pubitemid 30445912)
146. Yamaguchi S, Jeenes DJ, &, Archer DB, (2001) Protein-glutaminase from Chryseobacterium proteolyticum, an enzyme that deamidates glutaminyl residues in proteins. Purification, characterization and gene cloning. Eur J Biochem 268, 1410-1421. (Pubitemid 32231895)
147. Hsu Y, Jubelin G, Taieb F, Nougayrede JP, Oswald E, &, Stebbins CE, (2008) Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol 384, 465-477.
148. Yao Q, Cui J, Zhu Y, Wang G, Hu L, Long C, Cao R, Liu X, Huang N, Chen S, et al. (2009) A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc Natl Acad Sci USA 106, 3716-3721.
149. Crow A, Race PR, Jubelin G, Varela Chavez C, Escoubas JM, Oswald E, &, Banfield MJ, (2009) Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei. PLoS ONE 4, e5582.
150. Samba-Louaka A, Nougayrede JP, Watrin C, Jubelin G, Oswald E, &,
151. Chavez CV, Jubelin G, Courties G, Gomard A, Ginibre N, Pages S, Taieb F, Girard PA, Oswald E, Givaudan A, et al. (2010) The cyclomodulin Cif of Photorhabdus luminescens inhibits insect cell proliferation and triggers host cell death by apoptosis. Microbes Infect 12, 1208-1218.
152. Cui J, Yao Q, Li S, Ding X, Lu Q, Mao H, Liu L, Zheng N, Chen S, &, Shao F, (2010) Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329, 1215-1218.
153. McLaughlin LM, Govoni GR, Gerke C, Gopinath S, Peng K, Laidlaw G, Chien YH, Jeong HW, Li Z, Brown MD, et al. (2009) The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration. PLoS Pathog 5, e1000671.
154. Baldwin MR, Lakey JH, &, Lax AJ, (2004) Identification and characterization of the Pasteurella multocida toxin translocation domain. Mol Microbiol 54, 239-250. (Pubitemid 39315172)
155. Repella TL, Ho M, Chong TPM, Bannai Y, &, Wilson BA, (2011) Arf6-dependent intracellular trafficking of Pasteurella multocida toxin and pH-dependent translocation from late endosomes. Toxins 3, 218-241.
156. Oswald E, Nougayrede JP, Taieb F, &, Sugai M, (2005) Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol 8, 83-91. (Pubitemid 40203230)